Cargando…

Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer

The androgen receptor (AR) signaling pathway regulates the progression of prostate cancer (PC). Metastatic castration-resistant prostate cancer (mCRPC) patients generally receive AR-targeted therapies (ART) or androgen-deprivation therapies (ADT) with the initial response; however, resistance is ine...

Descripción completa

Detalles Bibliográficos
Autores principales:	McSweeney, Sean, Bergom, Hannah E, Prizment, Anna, Halabi, Susan, Sharifi, Nima, Ryan, Charles, Hwang, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259352/ https://www.ncbi.nlm.nih.gov/pubmed/37435458 http://dx.doi.org/10.1530/EO-22-0058

Ejemplares similares

Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study
por: Prizment, Anna E., et al.
Publicado: (2021)

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies
por: Hwang, Justin H, et al.
Publicado: (2022)

Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC)
por: Ryan, Charles J, et al.
Publicado: (2019)

Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy
por: Li, Zhenfei, et al.
Publicado: (2016)

ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems
por: Bergom, Hannah E., et al.
Publicado: (2023)

A self-supervised workflow for particle picking in cryo-EM
por: McSweeney, Donal M., et al.
Publicado: (2020)

Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
por: Schmidt, Andrew L., et al.
Publicado: (2021)

Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences
por: Chang, K-H, et al.
Publicado: (2014)

Conversion of abiraterone to D4A drives antitumor activity in prostate cancer
por: Li, Zhenfei, et al.
Publicado: (2015)

Association Between Asthma and Reduced Androgen Receptor Expression in Airways
por: McManus, Jeffrey M, et al.
Publicado: (2022)

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
por: Bae, Song Yi, et al.
Publicado: (2023)

Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer
por: Ko, Hyun-Kyung, et al.
Publicado: (2018)

Evaluation of androgen-induced effects on the uptake of [(18)F]FDG, [(11)C]choline and [(11)C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model
por: Emonds, Kimy M, et al.
Publicado: (2013)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

AB011. The regulatory effects of androgen in wound healing of the prostatic urethra after thulium laser resection of the prostate
por: Xia, Shujie
Publicado: (2018)

AB029. The regulatory effects of androgen in wound healing of the prostatic urethra after thulium laser resection of the prostate
por: Xia, Shujie
Publicado: (2017)

Potential Role of Conversational Agents in Encouraging PrEP Uptake
por: Hassani, Maryam, et al.
Publicado: (2022)

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
por: Mostaghel, Elahe A., et al.
Publicado: (2021)

Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases?
por: Leitsmann, Conrad, et al.
Publicado: (2019)

Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts
por: Sychev, Zoi E., et al.
Publicado: (2023)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer
por: Shi, Xiaolei, et al.
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
por: Baratchian, Mehdi, et al.
Publicado: (2022)

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
por: Olsen, Jan Roger, et al.
Publicado: (2016)

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
por: Chehrazi-Raffle, Alex, et al.
Publicado: (2023)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer
por: Jindal, Rashi, et al.
Publicado: (2023)

Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis
por: Podgórski, Rafał, et al.
Publicado: (2023)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
por: Lee, Eugine, et al.
Publicado: (2015)

Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation
por: Cui, Di, et al.
Publicado: (2023)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l4b9d51e0vlbpsid0j05e96t2j